| 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 产品1(元) | 33,295,610.13 | 73,681,766.62 | 37,648,042.89 |
| 产品4(元) | 13,109.73 | 4,262,437.21 | 1,855,088.49 |
| 胆固醇(元) | 178,982.30 | 1,191,814.18 | 1,037,389.39 |
| 非那甾胺中间体(元) | 26,357,446.66 | 90,461,094.90 | 42,813,111.69 |
| 甲基吡啶(元) | 115,198,926.07 | 71,552,392.81 | 11,833,751.19 |
| 木苦甾酮(元) | 71,632.73 | 1,788,424.79 | 1,682,230.10 |
| 营业成本(元) | |||
| 产品1(元) | 3,330,614.82 | 8,478,085.03 | 4,247,867.45 |
| 产品4(元) | 3,803.88 | 1,485,736.92 | 719,504.64 |
| 胆固醇(元) | 176,046.14 | 1,022,516.95 | 879,885.67 |
| 非那甾胺中间体(元) | 16,323,391.48 | 56,882,856.14 | 30,278,467.91 |
| 甲基吡啶(元) | 31,751,543.33 | 27,102,565.74 | 3,460,163.32 |
| 木苦甾酮(元) | 52,924.78 | 1,648,791.41 | 1,501,879.70 |
| 毛利(元) | |||
| 产品1(元) | 29,964,995.31 | 65,203,681.59 | 33,400,175.44 |
| 产品4(元) | 9,305.85 | 2,776,700.29 | 1,135,583.85 |
| 胆固醇(元) | 2,936.16 | 169,297.23 | 157,503.72 |
| 非那甾胺中间体(元) | 10,034,055.18 | 33,578,238.76 | 12,534,643.78 |
| 甲基吡啶(元) | 83,447,382.74 | 44,449,827.07 | 8,373,587.87 |
| 木苦甾酮(元) | 18,707.95 | 139,633.38 | 180,350.40 |
| 毛利率(%) | |||
| 产品1(%) | 90.00 | 88.49 | 88.72 |
| 产品4(%) | 70.98 | 65.14 | 61.21 |
| 胆固醇(%) | 1.64 | 14.21 | 15.18 |
| 非那甾胺中间体(%) | 38.07 | 37.12 | 29.28 |
| 甲基吡啶(%) | 72.44 | 62.12 | 70.76 |
| 木苦甾酮(%) | 26.12 | 7.81 | 10.72 |
| 收入构成(%) | |||
| 产品1(%) | 19.01 | 30.33 | 38.86 |
| 产品4(%) | 0.01 | 1.75 | 1.92 |
| 胆固醇(%) | 0.10 | 0.49 | 1.07 |
| 非那甾胺中间体(%) | 15.05 | 37.24 | 44.20 |
| 甲基吡啶(%) | 65.78 | 29.45 | 12.22 |
| 木苦甾酮(%) | 0.04 | 0.74 | 1.74 |
| 毛利构成(%) | |||
| 产品1(%) | 24.27 | 44.56 | 59.88 |
| 产品4(%) | 0.01 | 1.90 | 2.04 |
| 胆固醇(%) | 0.00 | 0.12 | 0.28 |
| 非那甾胺中间体(%) | 8.13 | 22.95 | 22.47 |
| 甲基吡啶(%) | 67.58 | 30.38 | 15.01 |
| 木苦甾酮(%) | 0.02 | 0.10 | 0.32 |